Speedchain | $111,000,000 | (Sep 10, 2025)
Aven | $110,000,000 | (Sep 10, 2025)
LightSpun | $13,000,000 | (Sep 10, 2025)
Ridge Bio
United States
- Palo Alto, CA
- 10/09/2025
- Seed
- $25,000,000
Ridge Biotechnologies is pioneering AI-based enzyme and targeted drug design to power the next wave of precision therapeutics.
Led by a collection of established biotech entrepreneurs and faculty from top institutions, we use proprietary machine learning models informed by high-throughput cell-free experimentation for a wide range of applications in antibody-drug conjugates (ADCs), conditionally active prodrugs, in vivo CART therapies, targeted nucleic acid delivery, radiotherapies, and enzyme-based therapeutics.
Our current product lines include NativeLink enzymes that enable precision bioconjugation including construction of ADCs and Antibody-oligonucleotide conjugates, ProTrigger linkers that provide tissue and disease-specific activation and release of diverse payloads and prodrugs, and new classes of enzyme-based Catalytic Medicines.
We are focused on enabling our partners to build better drugs for patients.
- Industry Biotechnology Research
- Website https://ridgebio.com/
- LinkedIn https://www.linkedin.com/company/ridge-bio/
Runware | $13,000,000 | (Sep 10, 2025)
Sphinx | $9,500,000 | (Sep 10, 2025)
Alchemab Therapeutics Ltd | Undisclosed Amount | (Sep 10, 2025)
SCINTIL Photonics | $58,000,000 | (Sep 10, 2025)
Aurva | $2,200,000 | (Sep 10, 2025)
Pathwork | $3,500,000 | (Sep 10, 2025)
Teton | $20,000,000 | (Sep 10, 2025)
Geordie AI | $6,500,000 | (Sep 10, 2025)